Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
|Poll|October 16, 2014
Firm, Nontender Mass on the Neck: Your Dx?
For several years, an asymptomatic, firm, nontender mass had been growing on the neck of a 54-year-old-man, slightly left of midline at the level of the hyoid bone. Thyroid function tests were normal. What does it indicate?
Advertisement
For several years, an asymptomatic, firm, nontender mass had been growing on the neck of a 54-year-old-man, slightly left of midline at the level of the hyoid bone. The mass was mobile on protrusion of the tongue and during swallowing. Thyroid function tests were normal. An axial thoracic CT scan was obtained.
What does it indicate?
Advertisement
Related to this article
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Tirzepatide gained an FDA cardiovascular indication after SURPASS-CVOT showed noninferiority to dulaglutide in high-risk adults.
FDA authorized Abbott’s Libre Duo 10 Day system, the first wearable device to continuously monitor both glucose and ketones.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia
2
Abbott Gains FDA Approval for CardioMEMS Update Letting Heart Failure Patients View Pressure Readings on Their Phones
3
Real-World Nonhormonal Therapy Effects on VMS Bother, Work, and Mood
4
Why Real-World Evidence Matters for Nonhormonal Menopause VMS Therapy
5